## Imaging and Staging Workup for Pancreatic Cancer with Obstructive Jaundice ### Standard Diagnostic Algorithm **Key Point:** Pancreatic cancer staging relies on **contrast-enhanced CT as the primary imaging modality**, supplemented by selective use of other investigations. PET-CT has limited role in initial diagnosis and staging of pancreatic adenocarcinoma. | Investigation | Role in Pancreatic Cancer | Indication | |---|---|---| | Contrast-enhanced CT (abdomen/pelvis) | Primary imaging; assess resectability, vascular involvement, metastases | All patients with suspected pancreatic cancer | | Diagnostic laparoscopy + laparoscopic ultrasound | Detect peritoneal/liver surface metastases; improve staging accuracy | Selected cases before planned resection | | Serum CA 19-9 | Prognostic marker; baseline for treatment monitoring | All patients; not diagnostic | | PET-CT | Limited sensitivity for pancreatic adenocarcinoma; may detect distant metastases | Selected cases with high suspicion for metastatic disease | | MRCP/EUS | Characterize biliary obstruction; tissue diagnosis if needed | Specific indications (stricture characterization, FNA) | ### Why PET Is NOT Primary Imaging for Pancreatic Cancer **High-Yield:** PET-CT has **poor sensitivity (~60–70%) for pancreatic adenocarcinoma** because: - Pancreatic tumors often have low FDG uptake (especially well-differentiated tumors) - High background uptake in normal pancreas and adjacent organs - Cannot reliably assess local tumor extent or vascular involvement **Clinical Pearl:** PET-CT is reserved for: - Detecting distant metastases in high-risk patients - Evaluating suspected recurrence after treatment - **NOT** for initial diagnosis or local staging. ### Correct Staging Sequence for Pancreatic Cancer 1. **Contrast-enhanced CT (multiphase)** → assess tumor size, local invasion, vascular involvement, distant metastases 2. **Serum CA 19-9** → baseline prognostic marker 3. **Diagnostic laparoscopy ± LUS** → if CT shows resectable disease; detect occult peritoneal/liver metastases 4. **EUS with FNA** → if tissue diagnosis needed or CT inconclusive 5. **PET-CT** → only if distant metastases suspected on CT but not confirmed **Warning:** Using PET as primary imaging delays diagnosis and may miss resectable disease. CT remains the gold standard for assessing resectability (pancreatic protocol CT with arterial, pancreatic, and portal venous phases). [cite:Sabiston Textbook of Surgery 21e Ch 55]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.